Executive Director of Policy and Information
Cancer Research UK is based in Stratford and Bow (London)
Cited in UK press coverage of health & social care
5 citations
Across 2 topics, first on 27 Aug 2026.
Dr Ian Walker is Executive Director of Policy and Information at Cancer Research UK (CRUK), the UK's leading cancer charity, headquartered at 2 Redman Place, London. He joined Cancer Research UK approximately 15 years before his 2021 appointment to the executive board, having previously served as Director of Research, where he oversaw a research funding budget of around £350 million, and led the charity's Early Detection of Cancer programme and national clinical network. In his current role he is responsible for the charity's government policy influencing work, public cancer information, and communications, with a particular focus on prevention and early diagnosis. He gave oral evidence to the Tobacco and Vapes Bill Committee in January 2025, arguing the case for the legislation that became the Tobacco and Vapes Act 2026. He is a prominent public voice on tobacco control, cancer health inequalities, NHS data access for research, and the conditions needed for UK cancer research and clinical trials to thrive.
Cited on
Stated areas of expertise
“Screening decisions must be guided by the current evidence, with programmes only introduced when the benefits are shown to outweigh the harms, including unnecessary and invasive overtreatment.”
Executive director of policy at Cancer Research UK · Hospital discharge / bed-blocking · 27 Aug 2026 · Most UK men should not be offered prostate cancer screening, experts say ↗
“the decision would be "disappointing for some" but was in line with evidence as there was some debate over the reliability of the PSA test”
director of policy at Cancer Research UK · Hospital discharge / bed-blocking · 27 Aug 2026 · Thousands more UK black men to be invited for prostate cancer screening ↗
“It can miss dangerous cancers and detect ones that don't need treatment.”
executive director of policy at Cancer Research UK · Cancer · 27 Aug 2026 · Expert panel advises against prostate cancer screening for most men in UK ↗
“the figures could be affected by overdiagnosis of the disease, 'where PSA tests in asymptomatic men could be spotting cancers that wouldn't cause any harm'”
executive director of policy at Cancer Research UK · Cancer · 27 Aug 2026 · Prostate cancer is most commonly diagnosed cancer across UK, study finds ↗
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.
“Whilst this review does highlight that the test could save one to two lives from prostate cancer for every 1,000 men screened, it also shows that around 30 more men could be diagnosed with the disease, many of whom would never have been harmed by their disease and could go on to have unnecessary treatment with long‑term impacts like the loss of bladder control and erectile dysfunction.”
Cancer Research UK · Cancer · 27 Aug 2026 · Prostate cancer screening can save lives but ‘absolute benefit is small’, study says ↗
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.